About Us

Shingles

Shingrix is a recombinant zoster vaccine designed to prevent shingles (herpes zoster) and its complications. It is approved for adults aged 50 and older, as well as immunocompromised individuals aged 18 and older. Shingrix works by stimulating a strong immune response to the varicella-zoster virus, which causes shingles. The vaccine is administered in two doses, given 2 to 6 months apart. Clinical studies have shown Shingrix to be over 90% effective in preventing shingles and its painful complications, making it a highly recommended option for adults to protect against this condition.